APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,450,740 | -55.7% | 879,357 | +6.1% | 0.01% | -54.5% |
| Q2 2023 | $75,478,355 | +16.3% | 828,522 | -15.8% | 0.02% | +10.0% |
| Q1 2023 | $64,872,254 | +27.6% | 983,509 | +0.1% | 0.02% | +25.0% |
| Q4 2022 | $50,827,155 | -21.6% | 982,927 | +3.6% | 0.02% | -30.4% |
| Q3 2022 | $64,801,000 | +111.2% | 948,759 | +39.9% | 0.02% | +109.1% |
| Q2 2022 | $30,678,000 | -7.9% | 678,401 | +3.5% | 0.01% | +10.0% |
| Q1 2022 | $33,297,000 | +19.0% | 655,308 | +10.7% | 0.01% | +25.0% |
| Q4 2021 | $27,986,000 | +63.7% | 591,914 | +14.1% | 0.01% | +33.3% |
| Q3 2021 | $17,100,000 | -35.4% | 518,811 | +23.9% | 0.01% | -33.3% |
| Q2 2021 | $26,460,000 | +52.6% | 418,666 | +3.6% | 0.01% | +50.0% |
| Q1 2021 | $17,342,000 | -19.3% | 404,127 | +7.6% | 0.01% | -33.3% |
| Q4 2020 | $21,479,000 | +92.7% | 375,499 | +1.6% | 0.01% | +80.0% |
| Q3 2020 | $11,146,000 | -5.8% | 369,428 | +2.0% | 0.01% | -16.7% |
| Q2 2020 | $11,833,000 | +33.4% | 362,289 | +9.4% | 0.01% | +20.0% |
| Q1 2020 | $8,870,000 | +7.5% | 331,083 | +22.9% | 0.01% | +25.0% |
| Q4 2019 | $8,250,000 | +31.2% | 269,413 | +3.2% | 0.00% | 0.0% |
| Q3 2019 | $6,290,000 | +1.1% | 261,084 | +6.4% | 0.00% | 0.0% |
| Q2 2019 | $6,221,000 | +50.9% | 245,472 | +16.1% | 0.00% | +33.3% |
| Q1 2019 | $4,123,000 | +62.4% | 211,408 | +9.9% | 0.00% | +50.0% |
| Q4 2018 | $2,539,000 | -25.8% | 192,439 | -0.1% | 0.00% | 0.0% |
| Q3 2018 | $3,424,000 | -9.6% | 192,559 | +11.8% | 0.00% | -33.3% |
| Q2 2018 | $3,788,000 | +301.3% | 172,179 | +303.3% | 0.00% | +200.0% |
| Q1 2018 | $944,000 | +9.4% | 42,691 | +7.4% | 0.00% | 0.0% |
| Q4 2017 | $863,000 | – | 39,742 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |